| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0047 | 1 |